Granite Investment Partners’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.09M | Sell |
3,718
-60
| -2% | -$38.5K | 0.13% | 153 |
|
|
2025
Q4 | $2.56M | Buy |
3,778
+34
| +0.9% | +$23.2K | 0.15% | 142 |
|
|
2025
Q3 | $2.39M | Sell |
3,744
-92
| -2% | -$55.8K | 0.14% | 149 |
|
|
2025
Q2 | $2.06M | Sell |
3,836
-16,116
| -81% | -$7.71M | 0.1% | 173 |
|
|
2025
Q1 | $8.38M | Sell |
19,952
-751
| -4% | -$326K | 0.43% | 82 |
|
|
2024
Q4 | $8.56M | Sell |
20,703
-1,779
| -8% | -$780K | 0.37% | 89 |
|
|
2024
Q3 | $11.4M | Sell |
22,482
-259
| -1% | -$126K | 0.49% | 74 |
|
|
2024
Q2 | $11.1M | Sell |
22,741
-58
| -0.3% | -$29.1K | 0.46% | 78 |
|
|
2024
Q1 | $12.3M | Sell |
22,799
-2,593
| -10% | -$1.42M | 0.47% | 76 |
|
|
2023
Q4 | $14.1M | Sell |
25,392
-949
| -4% | -$446K | 0.55% | 68 |
|
|
2023
Q3 | $11.5M | Sell |
26,341
-325
| -1% | -$162K | 0.48% | 75 |
|
|
2023
Q2 | $13.4M | Sell |
26,666
-1,558
| -6% | -$747K | 0.53% | 73 |
|
|
2023
Q1 | $14.1M | Buy |
28,224
+2,387
| +9% | +$1.14M | 0.59% | 66 |
|
|
2022
Q4 | $10.5M | Sell |
25,837
-1,879
| -7% | -$729K | 0.44% | 80 |
|
|
2022
Q3 | $9.03M | Buy |
27,716
+23,716
| +593% | +$8.71M | 0.39% | 86 |
|
|
2022
Q2 | $1.4M | Hold |
4,000
| – | – | 0.06% | 209 |
|
|
2022
Q1 | $2.19M | Hold |
4,000
| – | – | 0.07% | 201 |
|
|
2021
Q4 | $2.63M | Hold |
4,000
| – | – | 0.08% | 199 |
|
|
2021
Q3 | $2.49M | Hold |
4,000
| – | – | 0.08% | 193 |
|
|
2021
Q2 | $2.53M | Hold |
4,000
| – | – | 0.08% | 202 |
|
|
2021
Q1 | $1.96M | Hold |
4,000
| – | – | 0.07% | 203 |
|
|
2020
Q4 | $2M | Hold |
4,000
| – | – | 0.07% | 199 |
|
|
2020
Q3 | $1.57M | Hold |
4,000
| – | – | 0.07% | 201 |
|
|
2020
Q2 | $1.32M | Hold |
4,000
| – | – | 0.06% | 206 |
|
|
2020
Q1 | $969K | Hold |
4,000
| – | – | 0.06% | 211 |
|
|
2019
Q4 | $1.04M | Hold |
4,000
| – | – | 0.05% | 224 |
|
|
2019
Q3 | $1.09M | Hold |
4,000
| – | – | 0.06% | 227 |
|
|
2019
Q2 | $1.1M | Hold |
4,000
| – | – | 0.06% | 216 |
|
|
2019
Q1 | $894K | Hold |
4,000
| – | – | 0.05% | 242 |
|
|
2018
Q4 | $744K | Hold |
4,000
| – | – | 0.05% | 200 |
|
|
2018
Q3 | $999K | Hold |
4,000
| – | – | 0.06% | 174 |
|
|
2018
Q2 | $872K | Hold |
4,000
| – | – | 0.06% | 170 |
|
|
2018
Q1 | $766K | Hold |
4,000
| – | – | 0.05% | 188 |
|
|
2017
Q4 | $626K | Hold |
4,000
| – | – | 0.04% | 264 |
|
|
2017
Q3 | $622K | Hold |
4,000
| – | – | 0.04% | 254 |
|
|
2017
Q2 | $646K | Hold |
4,000
| – | – | 0.04% | 267 |
|
|
2017
Q1 | $618K | Hold |
4,000
| – | – | 0.04% | 268 |
|
|
2016
Q4 | $469K | Hold |
4,000
| – | – | 0.03% | 280 |
|
|
2016
Q3 | $451K | Hold |
4,000
| – | – | 0.03% | 277 |
|
|
2016
Q2 | $371K | Hold |
4,000
| – | – | 0.03% | 281 |
|
|
2016
Q1 | $313K | Hold |
4,000
| – | – | 0.03% | 288 |
|
|
2015
Q4 | $292K | Hold |
4,000
| – | – | 0.03% | 290 |
|
|
2015
Q3 | $297K | Hold |
4,000
| – | – | 0.03% | 279 |
|
|
2015
Q2 | $257K | Hold |
4,000
| – | – | 0.02% | 291 |
|
|
2015
Q1 | $309K | Hold |
4,000
| – | – | 0.03% | 278 |
|
|
2014
Q4 | $297K | Hold |
4,000
| – | – | 0.03% | 282 |
|
|
2014
Q3 | $236K | Hold |
4,000
| – | – | 0.03% | 279 |
|
|
2014
Q2 | $267K | Hold |
4,000
| – | – | 0.04% | 278 |
|
|
2014
Q1 | $243K | Hold |
4,000
| – | – | 0.04% | 240 |
|
|
2013
Q4 | $213K | Buy |
+4,000
| New | +$211K | 0.03% | 252 |
|
Other funds holding IDXX
VCM
VPM
Granite Investment Partners's IDXX Position: Q1 2026 in Review
Granite Investment Partners reduced its Idexx Laboratories (IDXX) stake by 1.6% in Q1 2026, selling an estimated $38.5K and leaving 3,718 shares worth $2.09M. The position accounts for 0.13% of the portfolio, ranked #153.
Granite Investment Partners first reported a position in IDXX in Q4 2013 and has held it in 50 quarters since. The position peaked at $14.1M in Q1 2023. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.
- Granite Investment Partners held 3,718 shares of Idexx Laboratories worth $2.09M as of Q1 2026.
- Granite Investment Partners sold 60 Idexx Laboratories shares in Q1 2026, an estimated $38.5K.
- Idexx Laboratories made up 0.13% of Granite Investment Partners's portfolio in Q1 2026, its #153 holding.
- Granite Investment Partners first reported a position in Idexx Laboratories in Q4 2013 and has held it in 50 quarters since.
- Granite Investment Partners's Idexx Laboratories position peaked at $14.1M in Q1 2023.
- 1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.
Based on Granite Investment Partners's 13F filing for Q1 2026, filed 30 Apr 2026.